Lawrence Klein is Chief Executive Officer of Oruka Therapeutics, Inc. (ORKA). The company reported total compensation of $3,356,050 for fiscal year 2025.
| Salary | $624,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $2,275,390 |
| Non-equity incentive plan | $446,160 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $10,500 |
| Total | $3,356,050 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Oruka Therapeutics, Inc. filed April 17, 2026, accession 0001213900-26-045159.
| Peer-group chief executive median | $3,837,737 |
|---|---|
| Difference from that median | $-481,687 |
| Percentile within the disclosed peer group | 27th |
| Peers with a disclosed figure | 10 |
Medians and percentiles are computed across the peer group Oruka Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Lawrence Klein this page | Chief Executive Officer | $3,356,050 |
| Joana Goncalves | Chief Medical Officer | $2,338,593 |
| Paul Quinlan | General Counsel and Corporate Secretary | $2,338,593 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Oruka Therapeutics, Inc. compensation brief.
Lawrence Klein's compensation sits inside Oruka Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.